ArticleMedicina (Kaunas, Lithuania)2024

Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression.

Yunus Emre Altıntaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.